Can a simple test predict who will benefit from prostate cancer radiation?
NCT ID NCT07370597
Summary
This study aims to understand why some prostate cancer patients don't respond to a targeted radiation treatment called 177Lu-PSMA-RLT. Researchers will measure how much radiation reaches tumors after one treatment cycle to see if this measurement can predict which patients will ultimately respond to the therapy. If successful, this could help doctors adjust treatment plans earlier for patients who aren't responding well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Jules Bordet
RECRUITINGBrussels, 1070, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.